Pfizer (PFE) is scheduled to report Q3 earnings on November 3, 2026. Analysts estimate EPS of $0.77 and quarterly revenue of $16.03B.
In the most recent quarter (Q2), Pfizer reported EPS of $0.77, beating estimates of $0.68 by 0.13%. Revenue came in at $15.03B, exceeding the estimate of $14.43B by 0.04%.
Pfizer has beaten EPS estimates in 8 consecutive quarters.
Over the last 4 quarters, Pfizer has averaged an EPS surprise of 0.17% and a revenue surprise of 0.03%.
Earnings Date
Nov 3
EPS Estimate
$0.770
Quarterly Revenue Estimate
$16.03B
Annual Revenue
$63.7B
as of Jun 30
Analyze the earnings history of Pfizer using advanced sorting and filters.
The chart below shows Pfizer's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Pfizer's reported revenue compared to analyst estimates over recent quarters.
Pfizer (PFE) is scheduled to report earnings on November 3, 2026. The last reported earnings were for reported on August 4, 2026 for Q2.
The Actual EPS was $0.77, which beat the estimate of $0.68.
The Actual Revenue was $15.03B, which beat the estimate of $14.43B.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $0.77 | $0.68 | 13.2 % |
| Q1 | May 5, 2026 | $0.75 | $0.72 | 4.17 % |
| Q4 | Feb 3, 2026 | $0.66 | $0.56 | 17.9 % |
| Q3 | Nov 4, 2025 | $0.87 | $0.65 | 33.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $15.03B | $14.43B | 4.22 % |
| Q1 | May 5, 2026 | $14.45B | $13.81B | 4.68 % |
| Q4 | Feb 3, 2026 | $17.56B | $16.87B | 4.08 % |
| Q3 | Nov 4, 2025 | $16.65B | $16.55B | 0.61 % |